PASITHEA THERAPEUTICS CORP. Cash and Cash Equivalents
PASITHEA THERAPEUTICS CORP. (KTTA) had Cash and Cash Equivalents of $45.66 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $45.66M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $50.40M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $55.16M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.12M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $45.66M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $50.40M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $55.16M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.12M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.22M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $5.34M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $6.92M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $9.36M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $7.97M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $12.01M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $16.33M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $19.58M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $26.65M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $29.91M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $33.09M 10-K · filed 2024-03-29 | $33.15M 10-K · filed 2023-03-30 |
| 2022-09-30 | $42.40M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $47.94M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $50.32M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $52.97M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $20.57M 10-Q · filed 2021-11-18 | |
| 2020-12-31 | $243.65K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $9.03K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |